Nanotech contact lenses give humans 'super vision,' even in total darkness with eyes shut: Study
After first testing in mice, scientists from China and the University of Massachusetts Chan Medical School created contact lenses for humans infused with specialized "nanoparticles," thousands of times smaller than a grain of sand, that let people see in the dark and in foggy conditions.
These nanoparticles are scattered throughout the soft lens material, where they absorb infrared light and convert it into images the human eye normally can't see.
Gang Han, the study's lead author and a Ph.D.-level nanoparticle researcher at UMass Chan Medical School, told ABC News the lenses enhance how someone sees color.
"When wearing them, you still see everything normally," Hans said. "The lenses simply add the ability to see infrared images on top of what we already normally see."
Wearing the lenses, participants were able to recognize coded flashes of infrared light — similar to Morse code — identify basic shapes and patterns, and even distinguish colors in the infrared range, effectively adding a new dimension to human vision, Han explained.
They could even perceive the images with their eyes closed, thanks to the ability of infrared light to pass through eyelids, he said.
MORE: FDA plans to limit COVID shots to those over 65 or with high-risk conditions
Humans can naturally see only visible light, a small slice of the full light spectrum that includes invisible wavelengths like ultraviolet and infrared. Night vision goggles can detect infrared light, but they're bulky, often need a power source, and usually show images in green or black and white, Han said.
"What's special about our contact lenses is that they let you see infrared light in color — like red, green and blue — so you can tell different things apart more easily," Han emphasized.
So far, the lenses have only been tested on a small group of individuals in China, all with normal vision.
Han said the researchers now need to test them in a more diverse population, including people with different vision capabilities.
"While we haven't specifically studied these lenses for people with vision impairments or eye diseases, this is an important area we hope to explore in the future," he said, adding that there needs to be further assessment to test their safety and spot any long-term effects to the eye.
MORE: Tropical cyclones may be linked to infant mortality in at-risk low- and middle-income countries, new research suggests
Advances in nanotechnology could bring everyday benefits, especially for first responders.
"Our lenses help rescuers see clearly and navigate safely in dangerous environments like fires or dense fog," he said.
Doctors already use infrared technology to highlight tumors treated with special dyes visible to infrared cameras. Han noted that the new lenses could enhance this approach by allowing surgeons to see near-infrared signals directly in their line of sight, without needing to glance at separate monitors.
"This study opens the door to many exciting applications of wearable technology, potentially transforming how we see and interact with our environment, especially in challenging conditions," he said.
The study was supported by the Human Frontier Science Program and included collaboration with U.S. scientists.
Dr. Karen Tachi Udoh is an internal medicine resident at Johns Hopkins Hospital and a member of the ABC News Medical Unit.
Nanotech contact lenses give humans 'super vision,' even in total darkness with eyes shut: Study originally appeared on abcnews.go.com
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Chicago Tribune
17 minutes ago
- Chicago Tribune
US pediatricians' new COVID-19 shot recommendations differ from CDC advice
NEW YORK — For the first time in 30 years, the American Academy of Pediatrics is substantially diverging from U.S. government vaccine recommendations. The group's new COVID-19 recommendations — released Tuesday — come amid a tumultuous year for public health, as vaccine skeptics have come into power in the new Trump administration and government guidance has become increasingly confusing. This isn't going to help, acknowledged Dr. James Campbell, vice chair of the AAP infectious diseases committee. 'It is going to be somewhat confusing. But our opinion is we need to make the right choices for children to protect them,' he added. The AAP is strongly recommending COVID-19 shots for children ages 6 months to 2 years. Shots also are advised for older children if parents want their kids vaccinated, the AAP said. That differs from guidance established under U.S. Health Secretary Robert F. Kennedy Jr., which doesn't recommend the shots for healthy children of any age but says kids may get the shots in consultation with physicians. Children ages 6 months to 2 years are at high risk for severe illness from COVID-19, and it was important that recommendations continue to emphasize the need for them to get vaccinated, said Campbell, a University of Maryland infectious diseases expert. Vaccinations also are recommended for older children who have chronic lung diseases or other conditions that put them at higher risk for severe disease, the AAP said. In a statement, Department of Health and Human Services spokesperson Andrew Nixon said 'the AAP is undermining national immunization policymaking with baseless political attacks.' He accused the group of putting commercial interests ahead of public health, noting that vaccine manufacturers have been donors to the AAP's Friends of Children Fund. The fund is currently paying for projects on a range of topics, including health equity and prevention of injuries and deaths from firearms. The 95-year-old Itasca, Illinois-based organization has issued vaccination recommendations for children since the 1930s. In 1995, it synced its advice with recommendations made by the federal government's Centers for Disease Control and Prevention. There have been a few small differences between AAP and CDC recommendations since then. For example, the AAP has advised that children get HPV vaccinations starting at age 9; the CDC says that's OK but has emphasized vaccinations at ages 11 and 12. But in 30 years, this is the first time the recommendations have differed 'in a significant or substantial way,' Campbell said. Until recently, the CDC — following recommendations by infectious disease experts — has been urging annual COVID-19 boosters for all Americans ages 6 months and older. But in May, U.S. Health Secretary Robert F. Kennedy Jr. announced that COVID-19 vaccines are no longer recommended for healthy children and pregnant women. A few days later, the CDC issued language that healthy children may get the shots, but that there was no longer a 'should' recommendation. The idea that healthy older kids may be able to skip COVID-19 boosters has been brewing for some time among public health experts. As the COVID-19 pandemic has waned, experts have increasingly discussed the possibility of focusing vaccination efforts on people 65 and older — who are among those most as risk for death and hospitalization. A CDC expert panel in June was set to make recommendations about the fall shots. Among the options the panel was considering was whether suggest shots for high-risk groups but still giving lower-risk people the choice to get vaccinated. But Kennedy bypassed the group, and also decided to dismiss the 17-member panel and appoint his own, smaller panel, that included vaccine skeptics. Kennedy also later excluded the AAP, the American Medical Association and other top medical organizations from working with the advisers to establish vaccination recommendations. Kennedy's new vaccine panel has yet to vote on COVID-19 shot recommendations. The panel did endorse continuing to recommend fall flu vaccinations, but also made a decision that led to another notable difference with the AAP. The new advisory panel voted that people should only get flu vaccines that are packaged as single doses and do not contain the preservative thimerosal. The AAP said there is no evidence of harm from the preservative, and recommended doctors use any licensed flu vaccine product that's appropriate for the patient.


UPI
an hour ago
- UPI
21 state AG's ask feds to ban 'designer Xanax' after Kentucky ban
1 of 2 | "This deadly drug has no place in our communities, and now we have the tools needed to get it off the streets and protect more lives," two-term Democratic Gov. Andy Beshear (pictured at the August 2024 DNC in Chicago, Ill.) said Monday. File Photo by Tannen Maury/UPI | License Photo Aug. 19 (UPI) -- Kentucky designated "bromazolam" as a Schedule 1 controlled substance as Gov. Andy Beshear also led a push to have it designated similarly at the federal level. Beshear announced the effort to ban the drug, also known as "designer Xanax" Monday after bromazolam was detected in at least 48 overdose deaths in Kentucky last year. "This deadly drug has no place in our communities, and now we have the tools needed to get it off the streets and protect more lives," the two-term Democratic governor said in a statement. The governor's signature immediately banned the drug from being sold in Kentucky and empowered law enforcement to act and arrest for sales or possession. It also provides further tools for authorities in Beshear's statewide crackdown. A 2021 report suggested that overdose deaths linked to illicit "designer" drugs had surged in the United States a staggering 520% between 2019 and 2020 during the COVID-19 pandemic, according to data from 32 states and the District of Columbia. On Monday, the rumored Democratic presidential candidate pointed to "important progress" in Kentucky's fight against addiction with three straight years of declines in overdose deaths. "And we're committed to ensuring that work continues," Beshear added. Beshear's executive action this week reportedly came following a request by the state's Republican Attorney General Russell Coleman. "We live in a moment when as little as one pill can kill -- and is killing -- our kids," Coleman said Monday in a joint statement with Beshear. "I'm glad we could work together to tackle this grave threat," he added on the bipartisan effort to rid the streets of the "designer" bromazolam. In 1985 the federal government enacted its ban on the so-called "designer drug" Ecstasy entirely due to the fact it was created by chemists and Ecstasy spin-offs were starting to hit the streets. Coleman and 20 other GOP state attorneys general are now calling on the federal government to follow state actions. "Despite its clear dangers, bromazolam remains unscheduled at the federal level, creating significant challenges for law enforcement and public health officials trying to respond to this emerging crisis," read a letter in part to DEA Administrator Terry Cole signed by Coleman and Alabama's Attorney General Steve Marshall, Tim Griffin in Arkansas, Florida's James Uthmeier, Georgia Attorney General Chris Carr, Indiana's Attorney General Todd Rokita and Brenna Bird from Iowa, Liz Murrill of Louisiana, Lynn Fitch of Mississippi, Montana's Austin Knudsen, Mike Hilgers of Nebraska, Drew Wrigley of North Dakota, Dave Yost of Ohio, Oklahoma's Gentner Drummond, Pennsylvania's new Attorney General Dave Sunday, Alan Wilson of South Carolina, Marty Jackley of South Dakota, Jonathan Skrmetti of Tennessee, Virgina's Jason Miyares, John 'JB' McCuskey of West Virginia and Ken Paxton of Texas. Coleman's letter pointed to how the originally synthesized but never approved for medical use bromazolam is now being illegally sold on the streets and in online platforms. The band of Republican state chief law enforcement officers argues that without its scheduling on a federal level, bromazolam will continue to "evade traditional regulatory and prosecutorial tools," which they added will hinder interdiction efforts and enable "continued distribution through illicit channels." "Virginia took proactive action by scheduling bromazolam," Virginia's Attorney General Jason Miyares said Monday. "Now, I'm encouraging federal action to ensure every state has the same tools to protect Americans," the Republican AG and first Latino elected to statewide office in Virginia posted on social media.


The Hill
2 hours ago
- The Hill
Leading pediatric group breaks with RFK Jr., recommends COVID shots for young kids
The American Academy of Pediatrics (AAP) on Tuesday recommended that parents vaccinate all infants and young children against COVID-19, a break from Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and his criticism of widespread vaccination. The group recommended all infants and children 6 months through 23 months get vaccinated against COVID-19 to help protect against serious illness. Children under 2 years old are especially vulnerable to severe COVID-19 and should be prioritized for vaccination, AAP said, unless they have a known allergy to the vaccine or its ingredients. The COVID recommendations were part of AAP's broader guidance for parents and pediatricians ahead of respiratory virus season and come as medical groups fight against what they see as Kennedy's efforts to undermine childhood vaccinations, including against the coronavirus. Kennedy in May announced in a video posted on X that the Centers for Disease Control and Prevention (CDC) would no longer recommend routine COVID-19 shots for healthy children because of a lack of any clinical data to justify yearly vaccines. 'The AAP will continue to provide recommendations for immunizations that are rooted in science and are in the best interest of the health of infants, children and adolescents,' AAP President Susan J. Kressly said in a statement. 'Pediatricians know how important routine childhood immunizations are in keeping children, families and their communities healthy and thriving.' The CDC did not go as far as Kennedy wanted on COVID shots and instead recommended 'shared decision making' between parents and clinicians to decide whether a healthy child should get a shot. AAP also advised shared decision making for children ages 2-18 whose parent or guardian desires them to have the protection of the vaccine. But the Food and Drug Administration did not approve Moderna's COVID-19 vaccine for use in healthy young children, only those with a health condition that puts them at increased risk of severe illness. Since it was founded in 1930, AAP has published evidence-based vaccine guidance to support pediatricians. But it has not traditionally differed substantially from federal recommendations. AAP and HHS have been at odds for months, and tensions reached a head when Kennedy dismissed all the members of the CDC's Advisory Committee on Immunization Practices (ACIP) and replaced them with his own handpicked representatives, including some outright vaccine skeptics. AAP's recommendation 'differs from recent recommendations of the Advisory Committee on Immunization Practices of the CDC, which was overhauled this year and replaced with individuals who have a history of spreading vaccine misinformation,' the group said in a statement. AAP chose not to participate in the reconstituted panel's first meeting in June, calling it 'illegitimate.' Kennedy later excluded AAP along with other top medical organizations from working with the panel to research and help influence vaccination recommendations. For decades, ACIP recommended which shots Americans should get and when. The Affordable Care Act requires all insurance companies to cover, for free, the vaccines recommended by the panel. Those recommendations also help states decide which shots should be mandated for schoolchildren. The panel has yet to vote on COVID-19 shot recommendations. Kennedy's shake-up is throwing that system into chaos. Outside physician and public health groups have been pressuring insurance companies to continue covering vaccines, no matter what ACIP does. 'The AAP urges every insurer to cover all the vaccines that are included in this immunization schedule,' Kressly said in the statement. 'AAP is committed to working with our partners at the local, state and federal levels to make sure every child, in every community has access to vaccines.'